Leaders team for Insulin and T2 drugs etc

Cowboyjim

Well-Known Member
Messages
1,294
Biocon and Pfizer have teamed for the worldwide commercialization of Biocon's biosimilar versions of Insulin and Insulin analog products: Recombinant Human Insulin, Glargine, Aspart and Lispro.
http://www.prnewswire.com/news-rele...al-commercialization-agreement-105162969.html

The Max Planck Institute (MPI) of Biochemistry in Martinsried and GlaxoSmithKline GmbH & Co. KG (GSK) will jointly develop new drugs for the treatment of Type II diabetes. A scientist Axel Ullrich, Director at the MPI of Biochemistry, has had earlier success: he and fellow scientist Mathias Bäcker described the role of certain protein molecules - known as kinases - in connection with the development of T2 so likely GSK wants to bring innovative drugs using this approach to market.
http://www.medicalnewstoday.com/articles/204962.php

In another news item someone is dealing with how insulin sensitivity may explain link between obesity, memory problems...."The study shows that impaired insulin sensitivity, which generally accompanies obesity, may serve as a mediator between midlife obesity and cognitive decline later on". Cheery stuff... 8)
http://www.eurekalert.org/pub_releases/2010-10/uota-ism101910.php